Personalised melanoma vaccine cuts risk of death or recurrence by 42%
Kenya reports second Ebola death; UK approves psoriasis pill
A personalised mRNA vaccine for melanoma showed a 42% reduction in death or recurrence in a major trial, while Kenya reported a second Ebola death and several drug developments emerged, including a new psoriasis pill approved in the UK.